Plaque psoriasis is the most
common type of psoriasis and accounts for 80% to 90% cases of total psoriasis.
Plaque psoriasis is an autoimmune condition, wherein thick, red patches appear
on the skin. These plaques commonly appear on the knees, scalp, and elbows;
however, these can also appear on other body part. These are itchy, painful,
and can bleed.
Read Report Overview - https://www.transparencymarketresearch.com/plaque-psoriasis-treatment-market.html
The exact cause of plaque
psoriasis is unknown. The triggers of psoriasis include infections, severe
sunburns, stress, smoking, alcohol consumption, obesity, dry skin, and certain
medications. The common symptoms of plaque psoriasis include itching, pain,
stinging sensation, and skin tightness. Diagnosis of plaque psoriasis is
usually done with thorough skin examination. Occasionally, biopsy is also
recommended to confirm the condition.
Rise in prevalence of psoriasis
across the globe, increase in research expenditure in developing countries,
high level of unmet clinical needs in patients with psoriasis, surge in
awareness about the condition, and favorable reimbursement policies are the
major factors projected to drive the global plaque psoriasis treatment market
during the forecast period. However, there is no disease modifying treatment
available for the conditions and current treatment provides symptomatic relief
only. This factor acts as a major restraint of the global plaque psoriasis
treatment market.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=59793
The global plaque psoriasis
treatment market can be segmented based on therapy, drug class, and region. In
terms of therapy, the plaque psoriasis treatment market can be classified into
topical therapy, phototherapy, systemic agents, and biologic therapies. The
topical therapy segment dominated the market in 2017 and is projected to
sustain its leadership position during the forecast period. This is because
topical therapy is considered first line of treatment for plaque psoriasis.
Phototherapy involves exposing skin to UV light under medical supervision.
Phototherapy and systemic agents
are usually prescribed when topical therapy is inadequate. Based on drug class,
the global plaque psoriasis treatment market can be categorized into TNF-α
inhibitors, IL-17 inhibitors, and IL-12/23 inhibitors. The TNF-α inhibitors
segment dominated the market in 2017 due to its safety profile and significant
usage in the treatment of plaque psoriasis. The segment is expected to sustain
its leadership position between 2018 and 2026. TNF-α inhibitors block body’s
response to TNF, a protein produced by white blood cells, thereby suppressing
inflammation. These are also used in the treatment of rheumatoid arthritis
(RA), Crohn's disease, psoriatic arthritis, ankylosing spondylitis, and
psoriasis.
Request for Analysis of COVID-19 Impact on Plaque
Psoriasis Treatment Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=59793
In terms of region, the global
plaque psoriasis treatment market can be segmented into North America, Europe,
Asia Pacific, Latin America, and Middle East & Africa. North America is
projected to account for significant share of the global market during the
forecast period. Rise in prevalence of plaque psoriasis in the U.S. and rich
pipeline of drugs are the major factors anticipated to propel the market in
North America from 2018 to 2026.
According to the National
Psoriasis Foundation, nearly 7.5 million people in the U.S. suffer from
psoriasis, and plaque psoriasis is the most common type of the disease.
According to the World Psoriasis Day consortium, 125 million people suffer from
psoriasis across the globe. The plaque psoriasis treatment market in Asia
Pacific is expected to expand at a high CAGR between 2018 and 2026. This can be
attributed to increase in research expenditure and rise in awareness about the
disease among the population.
Pre Book Plaque Psoriasis Treatment Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=59793<ype=S
Key players operating in the
global plaque psoriasis treatment market are AbbVie, Inc., Pfizer, Inc., LEO
Pharma A/S, Johnson & Johnson Services, Inc., Eli Lilly and Company, UCB
S.A., Sun Pharmaceutical Industries Ltd., Celgene Corporation, Merck & Co.,
Inc., and Novartis AG.
More Trending Reports by Transparency Market Research –
Bispectral Index (BIS) Monitor Market: https://www.biospace.com/article/bispectral-index-bis-monitor-market-4-channel-monitor-sub-segment-to-offer-attractive-opportunities/
Read our Case study at https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up
About Us
Transparency Market Research is a
global market intelligence company providing global business information
reports and services. Our exclusive blend of quantitative forecasting and
trends analysis provides forward-looking insight for several decision makers.
Our experienced team of analysts, researchers, and consultants use proprietary
data sources and various tools and techniques to gather and analyze
information.
Our data repository is
continuously updated and revised by a team of research experts so that it
always reflects latest trends and information. With a broad research and
analysis capability, Transparency Market Research employs rigorous primary and
secondary research techniques in developing distinctive data sets and research
material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free:
866-552-3453
Website: https://www.transparencymarketresearch.com/
